Crossmark

Vorasidenib: a new hope or a false promise for patients with low-grade glioma?

Crossref DOI link: https://doi.org/10.1038/s41571-024-00944-5

Published Online: 2024-09-12

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lazarev, Stanislav https://orcid.org/0000-0002-4397-9103
Sindhu, Kunal K.
License Information

Text and Data Mining valid from 2024-09-12

Version of Record valid from 2024-09-12
More Information

Article History

First Online: 12 September 2024

Competing interests

: The authors declare no competing interests.